On the Horizon: Asciminib, a New Drug for Treating R/R CML
News: Latest | Digests | Channels | Categories | Gallery
Posted on: December 14, 2020
Category: News , Hematology-Oncology
On the Horizon: Asciminib, a New Drug for Treating R/R CML
A first-in-class STAMP inhibitor, asciminib, shows better efficacy than bosutinib in patients with relapsed/refractory chronic myeloid leukemia in the chronic phase.
Medscape Medical News
Welcome to the healthcare-only HIPAA - GDPR compliant cloud. Exclusively hosted on a HPC environment!
Learn more or start today by choosing your secure HIPAA - GDPR compliant server's Operating System bellow and pick the package that's best for you.
BIPmd makes it simple to launch in the cloud and scale up as you grow – whether you’re running one virtual machine, thousand or more.
Looking for a custom solution?
Our technicians can provide you with the best custom-made solutionss on the market, no matter whether you're a small business or large enterprise.
Get in touch